SouthState’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Other funds holding IONS
SouthState's IONS Position: Q3 2026 in Review
SouthState held its Ionis Pharmaceuticals (IONS) position steady in Q3 2026 at 14 shares worth $626. The position accounts for ﹤0.01% of the portfolio, ranked #1226.
SouthState first reported a position in IONS in Q1 2025 and has held it in 7 quarters since. The position peaked at $3.59K in Q1 2025. 351 funds tracked by Wall St. Rank hold IONS as of Q3 2026.
- SouthState held 14 shares of Ionis Pharmaceuticals worth $626 as of Q3 2026.
- SouthState left its Ionis Pharmaceuticals share count unchanged in Q3 2026.
- Ionis Pharmaceuticals made up ﹤0.01% of SouthState's portfolio in Q3 2026, its #1226 holding.
- SouthState first reported a position in Ionis Pharmaceuticals in Q1 2025 and has held it in 7 quarters since.
- SouthState's Ionis Pharmaceuticals position peaked at $3.59K in Q1 2025.
- 351 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.
Based on SouthState's 13F filing for Q3 2026, filed 9 Nov 2026.